Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

Uwe Platzbecker; Martin Wermke; J. Radke; Uta Oelschlaegel; Franzi Seltmann; Alexander Kiani; I-M Klut; Holger Knoth; Christoph Röllig; Johannes Schetelig; Brigitte Mohr; Xina Graehlert; Gerhard Ehninger; Martin Bornhäuser; Christian Thiede

doi:10.1038/leu.2011.234

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

Uwe Platzbecker(University Hospital Carl Gustav Carus), Martin Wermke(University Hospital Carl Gustav Carus), J. Radke(University Hospital Carl Gustav Carus), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Franzi Seltmann(University Hospital Carl Gustav Carus), Alexander Kiani(University Hospital Carl Gustav Carus), I-M Klut(University Hospital Carl Gustav Carus), Holger Knoth(University Hospital Carl Gustav Carus), Christoph Röllig(University Hospital Carl Gustav Carus), Johannes Schetelig(University Hospital Carl Gustav Carus), Brigitte Mohr(University Hospital Carl Gustav Carus), Xina Graehlert(University Hospital Carl Gustav Carus), Gerhard Ehninger(University Hospital Carl Gustav Carus), Martin Bornhäuser(University Hospital Carl Gustav Carus), Christian Thiede(University Hospital Carl Gustav Carus)

Leukemia

September 2, 2011

10.1038/leu.2011.234

Cited by 395Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis